| Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia J Horacek, V Bubenikova-Valesova, M Kopecek, T Palenicek, C Dockery, ... CNS drugs 20, 389-409, 2006 | 635 | 2006 |
| Models of schizophrenia in humans and animals based on inhibition of NMDA receptors V Bubeníková-Valešová, J Horáček, M Vrajová, C Höschl Neuroscience & Biobehavioral Reviews 32 (5), 1014-1023, 2008 | 410 | 2008 |
| Psilocybin–summary of knowledge and new perspectives F Tylš, T Páleníček, J Horáček European Neuropsychopharmacology 24 (3), 342-356, 2014 | 369 | 2014 |
| Relationship of ketamine’s antidepressant and psychotomimetic effects in unipolar depression P Sos, M Klirova, T Novak, B Kohutova, J Horacek, T Palenicek Neuroendocrinol Lett 34 (4), 101-107, 2013 | 256 | 2013 |
| The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants J Prasko, J Horácek, R Zalesky, M Kopecek, T Novak, B Paskova, ... Neuroendocrinology Letters 25 (5), 340-348, 2004 | 211 | 2004 |
| The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder J Praško, B Pašková, R Záleský, T Novák, M Kopeček, M Bareš, ... Neuroendocrinology Letters 27 (3), 2006 | 207 | 2006 |
| Bridging disparate symptoms of schizophrenia: a triple network dysfunction theory T Nekovarova, I Fajnerova, J Horacek, F Spaniel Frontiers in behavioral neuroscience 8, 171, 2014 | 161 | 2014 |
| Effect of low-frequency rTMS on electromagnetic tomography (LORETA) and regional brain metabolism (PET) in schizophrenia patients with auditory hallucinations J Horacek, M Brunovsky, T Novak, L Skrdlantova, M Klirova, ... Neuropsychobiology 55 (3-4), 132-142, 2007 | 152 | 2007 |
| Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: voxel-based-morphometry (VBM) study J Horacek, J Flegr, J Tintera, K Verebova, F Spaniel, T Novak, ... The World Journal of Biological Psychiatry 13 (7), 501-509, 2012 | 143 | 2012 |
| The double-blind sham-controlled study of high-frequency rTMS (20Hz) for negative symptoms in schizophrenia: negative results T Novak, J Horacek, P Mohr, M Kopecek, L Skrdlantova, M Klirova, ... Neuroendocrinology Letters 27 (1-2), 209-213, 2006 | 123 | 2006 |
| Electroencephalographic spectral and coherence analysis of ketamine in rats: correlation with behavioral effects and pharmacokinetics T Páleníček, M Fujáková, M Brunovský, M Balíková, J Horáček, I Gorman, ... Neuropsychobiology 63 (4), 202-218, 2011 | 109 | 2011 |
| The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating V Bubeníková, M Votava, J Horáček, T Páleníček, C Dockery Pharmacology Biochemistry and Behavior 80 (4), 591-596, 2005 | 109 | 2005 |
| Differences in onset of disease and severity of psychopathology between toxoplasmosis‐related and toxoplasmosis‐unrelated schizophrenia D Holub, J Flegr, E Dragomirecka, M Rodriguez, M Preiss, T Novak, ... Acta Psychiatrica Scandinavica 127 (3), 227-238, 2013 | 104 | 2013 |
| Increased interleukin-6 and tumor necrosis factor alpha in first episode schizophrenia patients versus healthy controls A Kubistova, J Horacek, T Novak Psychiatria danubina 24 (suppl 1), 153-156, 2012 | 91 | 2012 |
| The relationship between central serotonergic activity and insulin sensitivity in healthy volunteers J Horáček, M Kuzmiaková, C Höschl, M Andĕl, R Bahbonh Psychoneuroendocrinology 24 (8), 785-797, 1999 | 87 | 1999 |
| Medial frontal and dorsal cortical morphometric abnormalities are related to obsessive-compulsive disorder J Kopřivová, J Horáček, J Tintěra, J Praško, M Raszka, I Ibrahim, C Höschl Neuroscience letters 464 (1), 62-66, 2009 | 84 | 2009 |
| Spatial knowledge impairment after GPS guided navigation: Eye-tracking study in a virtual town L Hejtmánek, I Oravcová, J Motýl, J Horáček, I Fajnerová International Journal of Human-Computer Studies 116, 15-24, 2018 | 83 | 2018 |
| The effect of repetitive transcranial magnetic stimulation (rTMS) add on serotonin reuptake inhibitors in patients with panic disorder: a randomized, double blind sham … J Prasko, R Zalesky, M Bares, J Horacek, M Kopecek, T Novak, ... Neuroendocrinology Letters 28 (1), 33-38, 2007 | 83 | 2007 |
| Sex differences and serotonergic mechanisms in the behavioural effects of psilocin F Tylš, T Páleníček, L Kadeřábek, M Lipski, A Kubešová, J Horáček Behavioural Pharmacology 27 (4), 309-320, 2016 | 78 | 2016 |
| EEG source analysis in obsessive–compulsive disorder J Kopřivová, M Congedo, J Horáček, J Praško, M Raszka, M Brunovský, ... Clinical Neurophysiology 122 (9), 1735-1743, 2011 | 78 | 2011 |